ARCA BIOPHARMA INC's ticker is ABIOXXXX and the CUSIP is 00211Y407. A total of 17 filers reported holding ARCA BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,673,000 | +24.9% | 1,216,840 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,339,000 | -55.1% | 1,216,840 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $2,981,000 | -2.0% | 1,216,840 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $3,042,000 | -12.3% | 1,216,840 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $3,468,000 | -1.4% | 1,216,840 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $3,517,000 | -0.3% | 1,216,840 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $3,529,000 | -15.5% | 1,216,840 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $4,174,000 | -26.2% | 1,216,840 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $5,658,000 | -6.4% | 1,216,840 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $6,048,000 | – | 1,216,840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 778,211 | $2,700,000 | 0.34% |
| NEA Management Company, LLC | 1,460,209 | $5,067,000 | 0.34% |
| Tekla Capital Management LLC | 811,227 | $2,783,000 | 0.12% |
| ROYCE & ASSOCIATES LP | 179,757 | $617,000 | 0.00% |
| Virtu KCG Holdings LLC | 15,690 | $54,000 | 0.00% |
| FRANKLIN RESOURCES INC | 1,216,840 | $4,174,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 142 | $0 | 0.00% |
| DEUTSCHE BANK AG\ | 37,700 | $130,000 | 0.00% |
| CITIGROUP INC | 5 | $0 | 0.00% |
| Walleye Trading LLC | 1,100 | $4,000 | 0.00% |